Neurocognitive deficits attributed to androgen deprivation therapy in patients with prostate cancer should be reconsidered.

Guan, Xin; Lao, Yongfeng; Bai, Yanan; Wang, Jian; Dong, Zhilong

Guan, Xin; Lao, Yongfeng; Bai, Yanan; Wang, Jian; Dong, Zhilong.

Afiliación

Guan X; Second Clinical Medical College, Lanzhou University, Lanzhou, China.
Lao Y; Department of Urology, Lanzhou University Second Hospital, No. 82, Cuiyingmen, Chengguan District, Lanzhou, China.
Bai Y; Second Clinical Medical College, Lanzhou University, Lanzhou, China.
Wang J; Department of Urology, Lanzhou University Second Hospital, No. 82, Cuiyingmen, Chengguan District, Lanzhou, China.
Dong Z; Second Clinical Medical College, Lanzhou University, Lanzhou, China.

Int Urol Nephrol ; 56(1): 143-144, 2024 Jan.

Article en En | MEDLINE | ID: mdl-37707708

Asunto(s)

Neoplasias de la Próstata; Masculino; Humanos; Neoplasias de la Próstata/tratamiento farmacológico; Antagonistas de Andrógenos/efectos adversos; Andrógenos; Factores de Riesgo

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Límite: Humans / Male Idioma: En Revista: Int Urol Nephrol Año: 2024 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google